538837 — Jeevan Scientific Technology Income Statement
0.000.00%
Last trade - 00:00
- IN₹811.78m
- IN₹849.33m
- IN₹361.78m
C2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | Interim Report | ARS |
Standards: | — | IAS | IAS | — | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 261 | 249 | 475 | 566 | 362 |
Cost of Revenue | |||||
Gross Profit | 245 | 240 | 468 | 492 | 332 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 238 | 342 | 335 | 432 | 400 |
Operating Profit | 22.9 | -93.3 | 139 | 134 | -37.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13.7 | -105 | 136 | 183 | -36.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.1 | -85.9 | 117 | 123 | -30.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11.1 | -85.9 | 117 | 123 | -30.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.1 | -85.9 | 117 | 123 | -30.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.74 | -5.61 | 7.67 | 8.15 | -1.98 |
Dividends per Share |